نتایج جستجو برای: picotamide

تعداد نتایج: 26  

2014
Fouad Amraoui Léon Spijkers Hajar Hassani Lahsinoui Liffert Vogt Joris van der Post Stephan Peters Gijs Afink Carrie Ris-Stalpers Bert-Jan van den Born

OBJECTIVE Scavenging of vascular endothelial growth factor (VEGF) elevates blood pressure (BP) in patients receiving anti-angiogenic therapy. Similarly, inhibition of circulation VEGF by its soluble receptor fms-like tyrosine kinase-1 (sFlt-1) underlies BP elevation in pre-eclampsia. Both phenotypes are characterized by augmented production of endothelin-1 (ET-1), suggesting a role for ET-1 in ...

Journal: :Thrombosis and haemostasis 1999
B Girolami E Bernardi M H Prins J W ten Cate P Prandoni R Hettiarachchi E Marras P M Stefani A Girolami H R Büller

BACKGROUND There is no consensus on the efficacy of the antithrombotic drugs available for patients with intermittent claudication. METHODS A Medline and manual search was used to identify relevant publications. Uncontrolled or retrospective studies, double reports or trials without clinical outcomes were excluded. Included studies were graded as level 1 (randomised and double- or assessor-bl...

2006
Carola Buccellati Angelo Sala Giuseppe Rossoni Valérie Capra G. Enrico Rovati Antonio Di Gennaro Giancarlo Folco Susanna Colli Cesare Casagrande

Thromboxane (TX) A2, prostacyclin (PGI2), and nitric oxide (NO) regulate platelet function and interaction with the vessel wall. Inhibition of TXA2, implemented synthesis of PGI2, and supply of exogenous NO may afford therapeutic benefit. 2NTX-99 [4-methoxy-N-(4-trans-nitrooxycyclohexyl)-N-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a new chemical entity related to picotamide, showed antithr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید